Tag: pharmaceutical news
Pfizer-BioNTech’s Updated COVID-19 Vaccine Gets FDA Nod for 2026-2027
Pfizer Inc. and BioNTech SE said Thursday that U.S. regulators have cleared their refreshed COVID-19 shot, giving American providers a strain-matched option just as the fall...
Amylyx Pharmaceuticals Announces Positive Phase 3 Trial Results for Avexitide, for Post-Bariatric Hypoglycemia
Amylyx Pharmaceuticals has announced positive top-line results from its pivotal Phase 3 LUCIDITY trial evaluating avexitide, a first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist being...
AstraZeneca Halts Phase III eVOLVE-Lung02 Trial of Volrustomig in Advanced Lung Cancer
AstraZeneca has announced it is stopping its Phase III eVOLVE-Lung02 study, which was testing volrustomig combined with chemotherapy as a first-line treatment for metastatic non-small cell...
Mankind Pharma Reports Strong Start to FY27 with 12.9% YoY Revenue Growth to ₹4,031 Crore
Mankind Pharma Ltd. 6 announced its financial results for the first quarter of FY27, delivering robust top-line and bottom-line expansion driven by steady chronic therapy demand,...
Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
Lupin Limited announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA)...
Cipla Receives U.S. FDA Approval for Generic Advair Diskus®️
Cipla Limited and its wholly owned subsidiary, Cipla USA Inc., have received approval from the U.S. Food and Drug Administration (FDA) for their Abbreviated New Drug Application...
